Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
6.68
-0.40 (-5.65%)
At close: Jan 2, 2026, 4:00 PM EST
6.81
+0.13 (1.95%)
After-hours: Jan 2, 2026, 4:28 PM EST
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $463.38 million as of January 2, 2026. Its market cap has decreased by -55.61% in one year.
Market Cap
463.38M
Enterprise Value
-179.20M
1-Year Change
-55.61%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $463.38M, an increase of 118.21%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 463.38M | -5.65% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |